Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Cardiovasc Pharmacol ; 73(6): 394-396, 2019 06.
Article in English | MEDLINE | ID: mdl-31162248

ABSTRACT

We report the case of an elderly woman who developed exanthematic drug eruption after administration of efonidipine. An 84-year-old woman presented to emergency department with complaints of generalized itching and erythema since 4 days. She was on human-soluble insulin since 11 years. In view of her hypertension and left anterior descending artery stenosis, she was initiated on aspirin, clopidogrel, atorvastatin, pantoprazole, nebivolol, aldactone, and efonidipine a week ago. Her presenting complaints were initially managed with parenteral pheniramine maleate and hydrocortisone. She was admitted, and all her medications except antiplatelets and insulin were discontinued. She was prescribed topical beclomethasone and oral antihistamines for better control of her symptoms. To confirm the drug precipitating the reaction, she was rechallenged with efonidipine, 20 mg once daily on the third day of admission. She developed itching 8 hours after administering the medication, and efonidipine was stopped and nebivolol 5 mg once daily was restarted for hypertension. She did not develop any adverse event when the remaining medications were reinitiated. World Health Organization-Uppsala Monitoring Centre causality assessment criteria indicated a "certain" association. To the best of the knowledge of the authors, this is one among the first reported cases of efonidipine-induced exanthematic drug eruption.


Subject(s)
Calcium Channel Blockers/adverse effects , Dihydropyridines/adverse effects , Drug Eruptions/etiology , Exanthema/chemically induced , Nitrophenols/adverse effects , Skin/drug effects , Administration, Cutaneous , Administration, Oral , Aged, 80 and over , Drug Eruptions/drug therapy , Drug Eruptions/pathology , Exanthema/drug therapy , Exanthema/pathology , Female , Glucocorticoids/administration & dosage , Histamine Antagonists/administration & dosage , Humans , Organophosphorus Compounds/adverse effects , Skin/pathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL